As filed with the Securities and Exchange Commission on March 27, 2020

Registration No. 333-66566

______

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington,  D.C.  20549

                   

POST EFFECTIVE AMENDMENT NO. 1 TO

FORM S-8

REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OF 1933

                   

MICRON SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)



Delaware

(State or other jurisdiction of

incorporation of organization)

 

72-0925679

(I.R.S. Employer Identification No.)



25 Sawyer Passway, Fitchburg, MA 01420

(Address of Principal Executive Offices)



1987 INCENTIVE STOCK OPTION PLAN

MICRON EMPLOYEE STOCK OWNERSHIP PLAN

1994 STOCK OPTION PLAN FOR DIRECTORS

(Full titles of the plans)



William J. Laursen

President

Micron Solutions, Inc.

25 Sawyer Passway, Fitchburg, MA 01420

(Name and address of agent for service)



(978 345-5000)

(Telephone number, including area code, of agent for service)



Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act. 

Large accelerated filerAccelerated Filer

Non-accelerated filerSmaller reporting company  

Emerging growth company



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised





 


 

DEREGISTRATION OF UNSOLD SECURITIES

This Post-Effective Amendment No. 1 to the Registration Statement on Form S-8 is being filed in order to deregister all securities remaining unsold under that certain Registration Statement on Form S-8 (Registration No. 333-66566) which was filed on August 2, 2001 (the “Registration Statement”) to register 38,500 shares of the common stock of Micron Solutions, Inc. (known at such time as Arrhythmia Research Technology, Inc.) (the “Company”) issuable under the Arrhythmia Research Technology, Inc. 1987 Incentive Stock Option Plan, 90,000 shares of the common stock of the Company issuable under the Arrhythmia Research Technology, Inc. 1994 Stock Option Plan for Directors, and 52,591 shares of the common stock of the Company issuable under the Micron Employee Stock Ownership Plan The Registration Statement is hereby amended to remove from registration the securities registered but unsold under the Registration Statement.

On March 26, 2020, the Company filed a  Form 25 to delist the Company’s shares of common stock on the NYSE American. The Company intends to file Form 15 to terminate registration under Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and its duty to file reports under Section 15(d) of the Exchange Act.

 

 

 


 

SIGNATURES



Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all the requirements for filing on Form S-8 and has duly caused this Registration Statement on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the town of Fitchburg, Commonwealth of Massachusetts on March  27, 2020.



   MICRON SOLUTIONS, INC.

            

    By:       /s/ William J. Laursen          _

             William J. Laursen
President